NO20050428L - Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommer - Google Patents
Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommerInfo
- Publication number
- NO20050428L NO20050428L NO20050428A NO20050428A NO20050428L NO 20050428 L NO20050428 L NO 20050428L NO 20050428 A NO20050428 A NO 20050428A NO 20050428 A NO20050428 A NO 20050428A NO 20050428 L NO20050428 L NO 20050428L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- heteroarylcarbonylpiperazines
- arylcarbonylpiperazines
- benign
- malignant tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39302702P | 2002-06-29 | 2002-06-29 | |
PCT/EP2003/006555 WO2004002965A1 (de) | 2002-06-29 | 2003-06-20 | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050428L true NO20050428L (no) | 2005-01-25 |
Family
ID=30000964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050428A NO20050428L (no) | 2002-06-29 | 2005-01-25 | Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommer |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040097734A1 (xx) |
EP (1) | EP1517898A1 (xx) |
JP (1) | JP2005538968A (xx) |
CN (1) | CN100509790C (xx) |
AR (1) | AR040315A1 (xx) |
AU (1) | AU2003246571B2 (xx) |
BR (1) | BR0312294A (xx) |
CA (1) | CA2433983A1 (xx) |
HK (1) | HK1080840A1 (xx) |
HR (1) | HRP20050092A2 (xx) |
MX (1) | MXPA04012959A (xx) |
NO (1) | NO20050428L (xx) |
NZ (1) | NZ537916A (xx) |
PL (1) | PL375527A1 (xx) |
RU (1) | RU2335496C2 (xx) |
UA (1) | UA79286C2 (xx) |
WO (1) | WO2004002965A1 (xx) |
ZA (1) | ZA200409610B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078732A1 (fr) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
CA2525325A1 (en) * | 2003-05-01 | 2004-11-18 | Abbott Laboratories | Pyrazole-amides and sulfonamides as sodium channel modulators |
AR044586A1 (es) * | 2003-06-04 | 2005-09-21 | Aventis Pharma Sa | Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion |
FR2855825B1 (fr) * | 2003-06-04 | 2008-08-22 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
EP1645556A1 (en) * | 2004-10-07 | 2006-04-12 | Boehringer Ingelheim International GmbH | Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents |
CA2614919C (en) | 2005-07-25 | 2015-06-23 | Zachary Demko | 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders |
AU2007275301A1 (en) * | 2006-07-20 | 2008-01-24 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1 |
KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
KR101171507B1 (ko) * | 2007-08-13 | 2012-08-07 | 에프. 호프만-라 로슈 아게 | 신규 피페라진 아마이드 유도체 |
CN101597278B (zh) | 2008-06-04 | 2013-04-17 | 中国中化股份有限公司 | 酰胺类化合物及其制备与应用 |
US9212177B2 (en) * | 2009-08-05 | 2015-12-15 | Versitech Limited | Antiviral compounds and methods of making and using thereof |
US20120149715A1 (en) * | 2010-05-28 | 2012-06-14 | Yi Tsun Richard Kao | Compounds and methods for the treatment of viral infections |
KR101369584B1 (ko) | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
AU2017311691B2 (en) * | 2016-08-18 | 2021-12-02 | Vidac Pharma Ltd. | Piperazine derivatives, pharmaceutical compositions and methods of use thereof |
WO2018083704A1 (en) * | 2016-11-07 | 2018-05-11 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses |
WO2018083705A1 (en) * | 2016-11-07 | 2018-05-11 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (hk2)-expressing cancers |
RU2700576C1 (ru) * | 2019-05-07 | 2019-09-18 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Анксиолитическое средство |
CN111303132B (zh) * | 2020-03-19 | 2023-05-23 | 辽宁孚音生物科技有限公司 | 一种抗癌化合物及其制备方法和应用 |
CA3188730A1 (en) | 2020-08-12 | 2022-02-17 | Christopher Barnes | Methods and compositions for treating polycystic ovary syndrome |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1620016C3 (de) * | 1966-07-02 | 1979-08-30 | Merck Patent Gmbh, 6100 Darmstadt | 3-{Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung |
US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
FI770485A (xx) * | 1976-02-18 | 1977-08-19 | Bristol Myers Co | |
EP0385043A1 (en) * | 1989-02-28 | 1990-09-05 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) | New derivatives of 4-substituted piperazines |
JPH03218371A (ja) * | 1989-08-02 | 1991-09-25 | Takeda Chem Ind Ltd | ピラゾール誘導体 |
US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
CA2093646A1 (en) * | 1990-10-10 | 1992-04-11 | Jesse K. Wong | Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
DE4219247A1 (de) * | 1992-06-12 | 1993-12-16 | Bayer Ag | Verwendung von 3-arylsubstituierten 5-Alkyl-isoxazol-4-carbonsäurederivaten zur Bekämpfung von Endoparasiten, neue 3-arylsubstituierte 5-Alkyl-isoxazol-4-carbonsäurederivate und Verfahren zu ihrer Herstellung |
WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
US6262059B1 (en) * | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
PL325341A1 (en) * | 1996-06-29 | 1998-07-20 | Samjin Pharmaceutical Co | Derivatives od piperazine and method of obtaining them |
ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
AU2793199A (en) * | 1998-02-26 | 1999-09-15 | Neurogen Corporation | 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives,their preparation and their use as (ant-)agonists for gaba (a) brain receptors |
CA2362381C (en) * | 1999-02-10 | 2009-12-22 | Welfide Corporation | Amide compounds and medicinal use thereof |
WO2000051614A1 (en) * | 1999-03-03 | 2000-09-08 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferases |
RU2002110295A (ru) * | 1999-09-17 | 2003-12-10 | Милленниум Фармасьютикалс, Инк. (Us) | Ингибиторы фактора Ха |
DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
DE10035927A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
WO2002020436A2 (en) * | 2000-09-05 | 2002-03-14 | Neogenesis Pharmaceuticals, Inc. | Methods for forming combinatorial libraries combining amide bond formation with epoxide opening |
US20020072081A1 (en) * | 2000-09-06 | 2002-06-13 | Wai-Si Eng | Geranylgeranyl transferase inhibitor screening assay |
FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
DE10102053A1 (de) * | 2001-01-17 | 2002-07-18 | Merck Patent Gmbh | Piperazinylcarbonylchinoline und -isochinoline |
ES2180456B1 (es) * | 2001-07-20 | 2004-05-01 | Laboratorios S.A.L.V.A.T., S.A. | Isoxazoles sustituidos y su utilizacion como antibioticos. |
CN1620294A (zh) * | 2001-12-20 | 2005-05-25 | Osi药物公司 | 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途 |
-
2003
- 2003-06-20 MX MXPA04012959A patent/MXPA04012959A/es active IP Right Grant
- 2003-06-20 PL PL03375527A patent/PL375527A1/xx not_active Application Discontinuation
- 2003-06-20 JP JP2004516632A patent/JP2005538968A/ja active Pending
- 2003-06-20 EP EP03761482A patent/EP1517898A1/de not_active Withdrawn
- 2003-06-20 CN CNB038154854A patent/CN100509790C/zh not_active Expired - Fee Related
- 2003-06-20 WO PCT/EP2003/006555 patent/WO2004002965A1/de active IP Right Grant
- 2003-06-20 AU AU2003246571A patent/AU2003246571B2/en not_active Ceased
- 2003-06-20 NZ NZ537916A patent/NZ537916A/en unknown
- 2003-06-20 BR BR0312294-8A patent/BR0312294A/pt not_active IP Right Cessation
- 2003-06-20 RU RU2005102478/04A patent/RU2335496C2/ru not_active IP Right Cessation
- 2003-06-20 UA UA20041210297A patent/UA79286C2/uk unknown
- 2003-06-27 US US10/608,520 patent/US20040097734A1/en not_active Abandoned
- 2003-06-27 AR ARP030102359A patent/AR040315A1/es unknown
- 2003-06-27 CA CA002433983A patent/CA2433983A1/en not_active Abandoned
-
2004
- 2004-11-26 ZA ZA2004/09610A patent/ZA200409610B/en unknown
-
2005
- 2005-01-25 NO NO20050428A patent/NO20050428L/no not_active Application Discontinuation
- 2005-01-27 HR HR20050092A patent/HRP20050092A2/hr not_active Application Discontinuation
-
2006
- 2006-01-13 HK HK06100574.8A patent/HK1080840A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA04012959A (es) | 2005-05-16 |
RU2335496C2 (ru) | 2008-10-10 |
CN100509790C (zh) | 2009-07-08 |
HK1080840A1 (en) | 2006-05-04 |
AU2003246571A1 (en) | 2004-01-19 |
PL375527A1 (en) | 2005-11-28 |
RU2005102478A (ru) | 2005-07-20 |
WO2004002965A1 (de) | 2004-01-08 |
BR0312294A (pt) | 2005-04-12 |
AR040315A1 (es) | 2005-03-23 |
UA79286C2 (en) | 2007-06-11 |
EP1517898A1 (de) | 2005-03-30 |
CA2433983A1 (en) | 2003-12-29 |
JP2005538968A (ja) | 2005-12-22 |
CN1665792A (zh) | 2005-09-07 |
NZ537916A (en) | 2005-11-25 |
US20040097734A1 (en) | 2004-05-20 |
ZA200409610B (en) | 2005-05-25 |
HRP20050092A2 (en) | 2005-02-28 |
AU2003246571B2 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050428L (no) | Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommer | |
NO20030301L (no) | Nye heteroarylderivater og anvendelse derav som farmasöytika | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
NO20092033L (no) | Nye forbindelser | |
NO20044475L (no) | 2-(2,6-diklorfenyl)-diarulimidazoler | |
IS6647A (is) | Kínasólínafleiður til að meðhöndla æxli | |
NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
DE50310516D1 (de) | Fredericamycin-derivate | |
NO20061506L (no) | Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav | |
MY142019A (en) | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
BRPI0411365A (pt) | derivados de aminopiridina | |
AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
ATE370139T1 (de) | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs | |
NO20056030L (no) | Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer | |
MXPA06000302A (es) | Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
HK1063185A1 (en) | Quinoline derivatives and their use as tyrosine kinase inhibitors | |
DE602004014163D1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
NO20044526L (no) | Hemisterlinderivater og anvendelser derav | |
ATE311389T1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
DE60231426D1 (de) | Solubilisierte topoisomerase-gift-mittel | |
ATE429230T1 (de) | Chinazoline derivative und ihre anwendung in der krebsbehandlung | |
NO20053805L (no) | Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |